News

S&P Global Announces Earnings Call for First Quarter Results

S&P Global Announces Earnings Call for First Quarter Results

S&P Global Schedules Earnings Announcement and Conference Call

S&P Global's (NYSE: SPGI) first quarter financial results are set to be announced via news release on the upcoming Tuesday. This significant event allows investors, analysts, and all interested parties to gain insights into the company's performance and strategic direction.

Details of the Earnings Release

On Tuesday, a detailed earnings release will be made available at approximately 7:15 a.m. ET. Investors are encouraged to review the results through the company’s official channels. This transparency emphasizes S&P Global's commitment to keeping stakeholders informed.

Conference Call Information

The company will host a conference call and webcast at 8:30 a.m. ET on the same day. Presenters includes key executives such as Martina Cheung, the President and CEO, alongside Eric Aboaf, the CFO, and Mark Grant, Senior VP of Investor Relations. This engaging session is anticipated to cover vital aspects of the financial results and prospects.

Webcast Instructions

The conference call will be accessible live, and it will also be archived for later access. Investors can join the webcast via the Investor Relations section of S&P Global’s website, ensuring that all parties have an opportunity to participate, whether in real-time or through recorded sessions.

Telephone Access for Participants

Those wishing to join via phone are advised to dial in by 8:20 a.m. ET. U.S. callers can reach the call at (888) 603-9623, while international participants can connect using +1 (630) 395-0220. It’s essential for investors to have the conference passcode handy, which is S&P Global.

About S&P Global

S&P Global plays a crucial role in the financial ecosystem by providing essential intelligence that empowers governments, businesses, and individuals. The company’s data-driven insights enable clients to navigate investments and manage transitions effectively, contributing to sustainable growth across various industries.

Recognized globally, S&P Global delivers benchmarks, credit ratings, analytics, and solutions across capital markets. Their offerings are designed to assist leading organizations in anticipating future trends, allowing them to make informed decisions today that pave the way for tomorrow's opportunities.

Investor Relations Contact

For any inquiries related to investor relations, Mark Grant, the Senior Vice President, can be contacted directly. With a wealth of experience in finance and investor communication, he is a reliable source for stakeholders looking for clarity and insight into company developments.

Frequently Asked Questions

What is the date of S&P Global's earnings announcement?

The earnings announcement is scheduled for Tuesday, April 29, 2025.

What time will the conference call begin?

The conference call will start at 8:30 a.m. Eastern Time.

Who can participate in the conference call?

The presentation is open to all interested parties, including investors and analysts.

How can I access the archived webcast?

The archived webcast will be available on S&P Global's Investor Relations website after the live session.

What does S&P Global specialize in?

S&P Global provides solutions such as credit ratings, benchmarks, analytics, and workflow solutions across various markets globally.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading

Top 5 Most Recently Viewed Articles

NotHappening Launches Unique Luxury Streetwear in NYC

Updated Category News Views 456

A Bold Fashion Statement: NotHappening Launches Today, a remarkable fashion phenomenon has emerged, capturing the imagination of enthusiasts and critics alike. NotHappening, a daring new brand, has made its grand entrance into the world of luxury streetwear, and it's more than just a fashion label; it's a commentary on contemporary culture and the pervasive influence of...

Continue Reading
Hormone Evaluation Steps: Insights from Annette Asper

Updated Category News Views 27

Navigating Hormone Evaluations with Clarity In the labyrinth of healthcare, figuring out what's crucial for your well-being can be a tangled mess. Today's focus is unraveling the often-overlooked world of hormone evaluations. It's not just about popping pills based on hunches—it's about getting a well-rounded picture of your health. Annette Asper from Rewritten Klinik...

Continue Reading
Radix Launches Innovations in Asset Integrity at Amsterdam Event

Updated Category News Views 101

Radix Showcases Innovations in Digital Twin Technology Radix is all set to unveil its groundbreaking innovations in asset integrity and energy transition at the renowned Future Digital Twin & Generative AI Conference. Hosted at the Energy Transition Campus in Amsterdam, this event is a gathering of industry experts and technology leaders aimed at tackling significant...

Continue Reading
Genmab Gets FDA Approval for Epcoritamab Combo for Lymphoma

Updated Category News Views 182

Genmab's Epcoritamab Combination Therapy Approved Company Announcement Genmab A/S (NASDAQ: GMAB) has achieved an important milestone with the FDA's approval of Epcoritamab, marketed as EPKINLY®, combined with rituximab and lenalidomide, a trio set to offer hope to adults suffering from relapsed or refractory follicular lymphoma (R/R FL). Pivotal Phase 3 Study Results The...

Continue Reading
EchoStar Corporation Posts Strong Growth in Q2 Financials

Updated Category News Views 171

EchoStar Corporation Financial Results Overview EchoStar Corporation (NASDAQ: SATS) has released its impressive financial results for the recently concluded quarter. The results indicate a robust performance, emphasizing growth across several key business areas. The company has focused on enhancing its operational efficiencies while ensuring that customer experiences are...

Continue Reading